Atlas Trials

Ovarian Clear Cell Carcinoma

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ovarian Clear Cell Carcinoma

RecordFirmDate
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer (NCT05226507)Nuvectis Pharma, Inc.2021-12-31
Asian Multicenter Prospective Study of ctDNA Sequencing (NCT05099978)National Cancer Center, Japan2021-11-01
Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma (NCT04735861)Tongji Hospital2021-04-07
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas (NCT04104776)Novartis Pharmaceuticals2019-09-18
A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas (NCT03405454)National University Hospital, Singapore2017-10-09
A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma (NCT02837991)Celldex Therapeutics2016-06-01
Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium (NCT02866370)NHS Greater Glasgow and Clyde2015-04-01
A Study of ENMD-2076 in Ovarian Clear Cell Cancers (NCT01914510)University Health Network, Toronto2013-09-01

Track Ovarian Clear Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.